Sprague-Dawley rats were prenatally exposed to low levels of alcohol (1.0 g/kg)
Abstract
In the United States approximately 10-15% of women consume alcohol (ethanol) during pregnancy. Even low amounts of ethanol consumption during pregnancy can elicit long-term consequences. Prenatal experience with as few as 3 drinks has been associated with increase problem drinking in adulthood. Such effects are corroborated in rodents; however, the underlying neural adaptations contributing to this effect are not clear. In the current set of experiments, we investigated whether changes in ethanol responding following prenatal ethanol exposure involved kappa opioid receptor activation and expression.
Sprague-Dawley rats were prenatally exposed to low levels of alcohol (1.0 g/kg) during late gestation (gestational day 17-20: GD17-20) via intragastric intubation of pregnant dams. Following birth, ethanol intake, kappa and mu opioid-induced place conditioning, and kappa opioid receptor expression in mesolimbic brain regions was assessed in infant rats (postnatal day 14-15: PD14-15) that were offspring of dams given ethanol, vehicle, or untreated, during pregnancy.
Animals exposed to prenatal alcohol drank more alcohol later in life and exhibited significant changes in the kappa opioid system. While control subjects found kappa opioid activation aversive, animals exposed to ethanol prenatally exhibited either no aversion or appetitive responding. Further analysis revealed that synaptosomal kappa opioid receptor expression was significantly decreased in brain areas implicated in responding to ethanol. Overall, this data suggests that prenatal ethanol affects kappa opioid function and expression and that these changes may be involved in increased drinking later in life.
Introduction
Alcohol abuse is a worldwide concern affecting the lives of millions. While a large portion of the population drinks with little to no adverse consequences, a substantial number become dependent and abuse the drug with extremely adverse outcomes.
Experience with alcohol in the womb or during infancy has been show to predispose individuals to problematic alcohol consumption later in life. Epidemiological studies confirm that humans exposed prenatally to a moderate amount of ethanol are at risk for alcohol abuse as adolescents and subsequently as adults (Alati et al., 2006 (Alati et al., , 2008 Baer et al., 1998 Baer et al., , 2003 Yates et al., 1998) .
Preclinical studies seem to confirm these epidemiological results. For example, studies have shown that rats exposed to 1.0 or 2.0 g/kg ethanol on gestational days [17] [18] [19] [20] exhibit enhanced ethanol intake in mid-infancy and adolescence (Arias & Chotro 2005; Chotro et al., 2007; Chotro & Arias 2003; Molina et al., 1999; and learn conditioned preferences for doses of ethanol that untreated animals do not find reinforcing (Nizhnikov et al., 2006; Pautassi et al., 2012) . Specifically, prenatal exposure to ethanol (1 or 2 g/kg IG from G17 -20) increases the range of ethanol doses that 3-hour-old and 14 day-old rat pups find reinforcing in comparison to untreated or water exposed controls (Nizhnikov et al., 2006 , Pautassi et al., 2012 .
A possible mechanism by which these effect might occur has been discussed by coworkers (2001, 2004) . Their studies revealed that prenatal ethanol exposure can result in associative learning between the orosensory and the postabsorptive, reinforcing effects of ethanol. Later re-exposure to the taste or odor of ethanol may trigger drug seeking and intake. found that adolescent rats that had been exposed to ethanol during late gestation exhibited reduced baseline levels of c-fos activation in the prefrontal prelimbic area, an area involved in the extinction of learned associations. The mechanisms underlying this facilitative effect of prenatal ethanol on later ethanol intake remain however, largely unknown.
The endogenous opioid system plays a major role in ethanol reinforcement (Herz 1997; Vengeliene et al., 2008; Sommer et al., 2006; Méndez & Morales-Mulia 2008) .
General blockade of the opioid system by administration of naltrexone disrupts ethanol intake and reinforcement in selected and unselected strains of rats and other species (Stromberg et al., 1998; Goodwin et al., 2001; Kato 2008; Nizhnikov et al., 2009; Barson et al., 2010) , which has led to its application in treatment of alcoholism (Kranzler & Van Kirk 2001; Pettinati & Rabinowitz 2006) . Antagonism of mu and delta opioid systems also inhibits both ethanol intake and reinforcement in adult and infant rats (Barson et al., 2010; Hyytiä & Kiianmaa 2001; Lindholm et al., 2001; Mitchell et al., 2005 Nizhnikov et al., 2009 Pautassi et al., 2011) . Moreover, administration of the general opioid antagonist naloxone to the pregnant, intoxicated dam inhibits the facilitative effect of prenatal ethanol on subsequent ethanol intake (Miranda-Morales et al., 2010) .
The kappa opioid system has also been implicated in ethanol's motivational effects. Generally, kappa opioid receptors are present throughout the central nervous system (Atalli et al., 1990; Leslie & Loughlin, 1992 Petrillo et al., 1987) . Unlike the mu and delta opioid system, kappa activity appears to mediate the aversive properties of alcohol during infancy and adulthood in non-dependant rats (Land et al., 2009; Pillai et al., 1986; Pohorecky et al., 1989) . For example, 14-day old rats found ethanol reinforcing, when assessed in conditioned place or taste preference, only after blockade of kappa opioid receptors (Pautassi et al., 2012b) . Furthermore, selective kappa agonists attenuate ethanol intake in adult non-dependant rats while antagonists increase it (Mitchell et al., 2005; Logrip et al., 2009; Sandi et al., 1988; Matsuzawa et al., 1999; Jamensky & Gianoulakis 1997) . Intriguingly, animals which have been made ethanol dependant show the reverse response to kappa opioid manipulations, i.e. kappa antagonists reduce operant responding for and intake of ethanol (Walker & Koob 2008; Walker et al., 2011; Philpot et al., 2003) . This is most likely due to an up-regulation of the kappa opioid system resulting in increased responding for ethanol's negative reinforcing properties, with this effect being reversed by kappa opioid antagonists. Kappa opioid receptors are positioned pre-synaptically and tend to tonically inhibit dopamine release in the nucleus accumbens and in the prefrontal cortex via connections to the ventral tegmental area (see Sunil et al., 2012 for comprehensive review). Thus, changes in the function of this system (up-regulation) in dependent rats would explain their increased drinking and the effects of kappa opioid antagonism in these subjects. The above results are examples of a change in the endogenous opioid system due to experience with ethanol resulting in increased seeking and drinking of ethanol.
Experiments have shown changes in several opioid systems including the kappa opioid system after ethanol exposure in adulthood (Rosin et al., 1999; Turchan et al., 1999; Lindholm et al., 2000; Cowen & Lawrence 2001; Zapata & Shippenberg 2006; Sirohi et al., 2012) . For example, Rosin and colleagues (1999) reported down regulation of kappa opioid receptor mRNA in the ventral tegmental area (VTA) and nucleus accumbens (NAc). On the other hand Lindholm et al., (2000) found an upregulation of Dynorphin-B in the NAc. These results suggest that the function of the kappa opioid system may change after chronic ethanol exposure during adulthood. We hypothesize that similar changes may occur after prenatal exposure to ethanol resulting in increased intake of and reinforcement to ethanol later in life, increasing the likelihood of alcohol dependence. This possibility is especially intriguing given kappa's ontogenetic change in motivational properties (from appetitive to aversive) during the 1 st and 2 nd postnatal weeks (Barr GA 1993; Petrov et al., 2006; Bals-Kubik et al., 1993; Varlinskaya et al., 1996) . Specifically, Petrov et al., (2006) reported that newborn infant rats find kappa opioid receptor activation appetitive while adults have been shown to clearly find activation of kappa aversive.
The present study analyzed ethanol intake in preweanling rats following brief prenatal ethanol exposure during late gestation (Experiment 1). After establishing the reliability of increased ethanol intake following prenatal exposure to the drug, a subsequent experiment tested kappa opioid mediation of this phenomenon (Experiment 2). The possibility of prenatal ethanol affecting the motivational properties of both kappa and mu opioid signaling was then tested in Experiment 3 & 4, via second order conditioned place preference (Pautassi et al., 2011; .
Methods

Subjects
720 Sprague-Dawley male and female rat pups (postnatal day 14; PD14)
representative of 90 litters, were employed in Experiments 1 through 5. The animals were PD14 at the start of the experimental procedures. All litters were born and reared at the Center for Development and Behavioral Neuroscience (Binghamton University, USA). Two females (at least PD60) were caged with a single male. For the following week vaginal smears were taken and the day of sperm detection was considered gestational day 0 (GD0). Births were examined daily and the day of parturition was considered as postnatal day 0 (PD 0). On PD1 litters were culled to 10 pups (5 males and 5 females, whenever possible). Pups were housed with the dam in standard maternity cages with free access to water and food. The colony was kept at 22 -24 °C and a 12-hour light-dark cycle was used with light onset occurring at 700 AM. All procedures were in compliance with the Guide for Care and Use of Laboratory Animals (National Institutes of Health, 1986) and were also approved by the Institutional Animal Care and Use Committee within an AAALAC-accredited facility.
Prenatal Ethanol Treatment
The procedures were similar to those used in (Dominguez et al., 1998) . Untreated dams were kept under similar housing conditions as the previous two groups but did not receive any treatment across GDs 17-20.
Intraoral Cannulation
Experiments 1 (Spear et al., 1989; Pautassi et al., 2002) . The free end of the cannula was connected to PE-50 polyethylene tubing, which in turn was connected to a syringe placed in a 10-syringe infusion pump (KD Scientific, Holliston, MA). The size and schedule of the infusions was computer controlled. Unless stated otherwise, cannulation was performed 2 hr. prior to fluid infusion.
Drug Preparation
Norbinaltorphimine (nor-BNI: selective kappa opioid antagonist: Experiment 2), Spiradoline mesylate (U62,066E: selective kappa opioid agonist: Experiment 3), and
Tyr-d-Ala-Gly-N-Me-Phe-Gly-ol enkephalin (DAMGO: selective mu opioid agonist:
Experiment 4) (Sigma-Aldrich, St. Louis, MO) were administered via intraperitoneal (i.p.)
injections, as described in Nizhnikov et al., (2006b) . Briefly, 30 gauge needles were used, connected to 1cc tuberculin syringes. The site of the injection was located approximately halfway between the diaphragm and the genitalia, on the right side of the pup. Injections were executed in less than 10s. Injection volume was 0.01 ml/g for all doses and saline (0.9%) was employed as the vehicle solution. Nor-BNI was administered 24 hours prior to the start of testing to allow for the drug effects to be selective for kappa opioid receptors (Metcalf and Coop, 2005) .
Infant Fluid Intake Test (Experiments 1 & 2)
The procedures were similar to those used in Chotro et al., (Chotro and Arias, 2006) and Pautassi et al., (2012b) . Specifically, two hours prior to each days' intake test (Experiment 1: ethanol 5.0%, 10.0%, 20.0% or water; Experiment 2: ethanol 5.0% or water), pups were removed from the dam, cannulated (described above), and placed in pairs (1 male and 1 female) in a heated holding chamber. Each pair of animals received the same type of fluid infusions so that ethanol animals were never with water animals.
Following the 2 hour acclimation period pups were voided by gentle brushing of the anogenital region and weighed to the nearest 0.01 g. Pups were given intraoral infusion of either ethanol or water (total volume: 5.5% of body weight, duration of infusion: 15 min) in warmed, individual clear plastic chambers (8 cm × 8 cm × 25 cm). Previous studies indicate that these infusion parameters allow subjects to ingest or reject the fluid delivered at will (Pautassi et al., 2002) . At the end of the test, subjects were removed, dried, weighed, had their cannula removed, and either returned to their dams (Experiment 1) or to a warmed holding cage for 2 hours (Experiment 2). Following the 2 hours the pups were returned to their dams overnight. Percent body weight gain of fluid ingested was calculated as follows: ((Pre-test Body Weight -Post-test Body Weight) / Pre-test Body Weight) * 100.
For Experiment 1 the test occurred on PD14 only. For Experiment 2 rat pups received a single i.p. injection with one of 3 doses of nor-BNI (0.0 (saline), 2.5 mg/kg, or 10.0 mg/kg) on PD13 and were then immediately returned to their dam for 24 hours. The intake procedure as described above was then performed for 5 consecutive days starting on PD14.
Second-order conditioning and testing (Experiments 3 & 4)
Second-order conditioning (SOC), a variant of place conditioning, was conducted on postnatal days 14 (first-order conditioning) and 15 (test), as we have done previously (Pautassi et al., 2012b) . SOC allows for the detection of ethanol's appetitive or aversive effects across all ages (Molina et al., 2006; Pautassi et al., 2008 Pautassi et al., , 2011 , as well as the pharmacological dissection of these effects (Pautassi et al., 2011; 2012b) Phase 2 (second-order conditioning, PD 15): Animals were cannulated and placed in a warmed cage for 60 min as we have previously done (Pautassi et al., 2012b ). Second-order conditioning then began by placing the subjects into square chambers similar to those during Phase 1; however, the floor was covered with sandpaper (50 grit; Gatorgrit, Fairborn, OH). The animals remained in these cages for four minutes and were given pairings of sandpaper (conditioned stimulus 2, CS2) and the distilled water CS1. Specifically, distilled water was intraorally infused every 55 s 
Tissue Collection and Western Blot Analysis.
Two subjects (one male and one female) from each litter were not tested behaviorally but sacrificed via decapitation at PD14 and the brain was rapidly removed, flash frozen and stored at -80 O C until further use. The nucleus accumbens (nAc), hippocampus, amygdala (AMYG), and prefrontal cortex (PFC) were microdissected and assessed due to their involvement in addiction processes, memory, anxiety, impulse control, and drug reinstatement. Tissue was processed to determine receptor expression levels in P2 synaptosomal preparations as described elsewhere (Werner et al., 2011; Santerre et al., 2013) . Briefly, tissue was homogenized in 320 mM sucrose/phosphate buffered saline (PBS) solution and spun at low speed centrifugation (1,000 x g) and the subsequent supernatant was then spun again at 12,000 x g for 20 min. The resulting pellet (P2) was resuspended in PBS. Protein concentrations were quantified using a bicinchoninic acid method. Protein samples were subjected to SDS-polyacrylamide gel electrophoresis using Novex Tris-Glycine (8-16%) gels and transferred to polyvinylidene difluoride membranes (Invitrogen, Carlsbad, CA). Membranes were probed with a primary antibody for the kappa opioid receptor (Millipore, Billerica, MA)
followed by appropriate secondary antibody (Thermo Scientific, Waltham, MA). Bands were detected using enhanced chemiluminescence (GE Healthcare, Amersham, UK) and exposed to autoradiographic film under nonsaturating conditions. All membranes were reexposed to β-actin to control for loading. Densitometric analysis was conducted using NIH Image J software. All samples were assessed in duplicate to triplicate. In order to avoid overrepresentation of litters within each specific group, no more than 2 animals per litter (one male and one female) were assigned to each particular treatment. Sex was also considered as a factor; however, since this variable failed to exert significant main effects or interact with the remaining factors in all experiments, data were collapsed across this variable.
Results
Experiment 1: Prenatal ethanol exposure increases subsequent ethanol intake.
Experiment 1 assessed intake of several concentrations of ethanol or water in PD14 subjects as a function of prenatal treatment (percent body weight gain used as a measure of fluid intake). Analysis revealed main effects of fluid F(3, 88) = 40.12, p < 0.0001, and prenatal treatment F(2, 88) = 3.89, p < 0.05, as well as a fluid x prenatal treatment interaction F(6, 88) = 3.20, p < 0.01. All subjects drank less 20% ethanol than any other fluid. However, animals experiencing prenatal ethanol drank more 5.0%
ethanol than any other prenatal condition group, which did not differ from each other (Figure 1) . No other differences in fluid intake were seen as a function of prenatal treatment. It seems that the prenatal ethanol exposure protocol used here, albeit much briefer than the one employed in other studies (e.g., , reliably promotes ethanol intake of a moderately (i.e., 5.0 % v/v) concentrated solution, without altering overall patterns of fluid intake.
[Insert Figure 1 about here]
Experiment 2: Kappa opioid receptor activity mediates ethanol intake in controls but not in animals prenatally exposed to ethanol.
In Experiment 2 the effects of nor-BNI pretreatment (kappa opioid antagonist) on intake of ethanol or water across 5 days was analyzed as a function of prenatal treatment. As 5% ethanol concentration elicited robust increases in ethanol intake following prenatal ethanol exposure, this concentration was used for Experiment 2.
Preliminary analysis of animals injected with saline on PD13 revealed a main effect of prenatal treatment (F(2, 26) = 11.48, p < 0.001). Similar to Experiment 1, Animals exposed to ethanol prenatally exhibited higher ethanol consumption than the remaining conditions. In view of these baseline differences in ethanol intake and following the statistical approach employed by Varlinskaya and Spear (2012) , subsequent analyses were conducted separately based on prenatal treatment.
The ANOVA for prenatally untreated animals indicated a main effect of nor-BNI F(2, 100) = 5.03, p < 0.02, days F(4, 100) = 4.19, p < 0.01 and a nor-BNI x testing day interaction F(8, 100) = 2.61, p < 0.02. Further analysis indicated a slight, but significant, increase in ethanol intake on day 1 for animals given the 10 mg/kg nor-BNI dose (se For prenatally water treated animals, the analysis yielded a main effect of testing day F(4, 120) = 9.70, p < 0.0001; as well as a nor-BNI x testing day interaction F(8, 120) = 2.07, p < 0.05. Further analysis indicated that the 2.5 mg/kg nor-BNI dose slightly, but significantly, increased ethanol intake on day 1 of testing. However, a more robust significant increase in ethanol intake following 2.5 mg/kg nor-BNI administration was seen on day 5 (Figure 3) . A borderline effect was also observed for the 10 mg/kg dose at both days 1 and 5, but neither reached the level of significance.
The ANOVA for subjects treated prenatally with ethanol only revealed a main effect of testing day (F(4, 112) = 7.07, p < 0.0001). Ethanol intake was lower on day 2 than on any other test day and this pattern was similar in subjects given either dose of nor-BNI or vehicle (Figure 4) .
Overall, the results from this experiment indicate that the antagonism of kappa opioid receptors results in increased ethanol intake in control animals, particularly after repeated exposure to ethanol. This effect may be due to an attenuation of the aversive effects of ethanol. Perhaps a more important result was that prenatal ethanol made animals insensitive to this kappa-mediation of ethanol intake.
[Insert Figure This experiment indicates that prenatal ethanol may significantly alter the motivational tone of the endogenous kappa opioid system. Activation of this system induces, as expected, conditioned place avoidance in the offspring of control dams.
Prenatal ethanol disrupted the expression of this conditioned avoidance and even made animals prefer the kappa-related texture, when the 5 mg/kg dose was employed.
Experiment 4: Changes in responding to mu (DAMGO) opioid stimulation as a function of prenatal ethanol exposure.
Experiment 3 revealed that prenatal ethanol alters the sensitivity to the motivational consequences of KOR activation, an effect that may underlie the greater ethanol intake after prenatal exposure. Effects of prenatal exposure on the endogenous opioid system may be, however, broader, affecting functionality of mu receptors.
Experiment 4 assessed second-order conditioned place preference/aversion, induced by the administration of the mu agonist DAMGO.
The ANOVA for percent time spent in the DAMO-related sandpaper, indicated the lack of significant main effects for prenatal exposure or DAMGO treatment. No significant interactions were observed (see Figure 6 ).
These results, taken together with those derived from Experiment 3, indicate that the effects of prenatal ethanol exposure, at this age, may be more dependent on changes on kappa than on mu opioid receptor function. Given the involvement of kappa opioid receptors in ethanol intake and the observed changes in preference for kappa opioid activation following prenatal ethanol exposure, we wanted to assess whether kappa opioid expression correlated with the behavioral responses. Compared to controls, we found that prenatal ethanol exposure reduced synaptosomal kappa opioid receptor expression in the nucleus accumbens by 41.6% (t = 2.494, p < 0.05, Figure 7A ), as well as in the amygdala by 47.9% (t = 2.606, p < 0.05, Figure 7B ) and hippocampus by 52.5% (t = 3.259, p < 0.01, Figure 7C ). No differences were found for the prefrontal cortex ( Figure 7D ).
Insert Figure 5 about here
Discussion:
The current set of experiments tested the effects of brief prenatal exposure to physiologically relevant doses of ethanol during late gestation on ethanol intake, kappa opioid involvement in ethanol intake, and changes in kappa opioid function and expression.
The results indicate that relatively low prenatal ethanol exposure significantly increased drinking of 5.0% ethanol solution and decreased sensitivity to modulation of ethanol drinking by kappa opioid antagonists. Most strikingly, while control animals developed conditioned place aversions to textures paired with kappa agonists, experience with ethanol in the womb resulted in appetitive or neutral responding to kappa agonists. Changes in motivational responding after prenatal ethanol were specific to the kappa system, since no change was seen in response to a mu agonist.
Changes in preference for kappa opioid receptor activation were accompanied by a significant down regulation of kappa opioid receptor expression in brain regions critical for ethanol responding such as the nucleus accumbens, hippocampus, and amygdala.
These results are especially intriguing since the specific brain areas affected by prenatal ethanol have been implicated in responding for ethanol. This set of results is consistent with previous work indicating that prenatal ethanol significantly enhances sensitivity to ethanol-induced appetitive effects, reduces sensitivity to ethanol-induced aversion (Pautassi et al., 2012a) , and reduces baseline level of activation in the infralimbic area .
Increased intake of ethanol following prenatal exposure has been shown in the past, and this effect lasts into adolescence (i.e., Diaz-Cenzano and Chotro, 2010; . However, a thorough analysis of acceptance of different concentrations following prenatal ethanol exposure has been lacking. Our findings indicate that prenatal exposure to 1.0 g/kg ethanol during gestational days 17-20 increases the intake of 5.0%
but not 10.0% or 20.0% ethanol solution in PD14 rat pups (Experiment 1).
One possible reason for the increased intake is a change in the pharmacological reinforcing properties of ethanol following prenatal exposure. We have previously shown that animals experiencing ethanol prenatally find higher doses of ethanol reinforcing compared to controls (Nizhnikov et al., 2006a; Pautassi et al., 2012b) . Similarly, in the present study changes in the reinforcing properties of a selective kappa agonist were attributed to prenatal ethanol. Control subjects found kappa opioid activation aversive, a result that was expected given that activation of the kappa opioid system has been shown to mediate the aversive properties of stress (Land et al., 2009 ) and that kappa agonists are aversive for adult animals (Mucha and Herz, 1985; Shippenberg and Herz, 1986; Bals-Kubik et al., 1989) . Conversely, animals prenatally exposed to alcohol formed either preference for a texture paired with a kappa agonist or did not form an aversion (Experiment 3). This set of results suggests that prenatal ethanol induces a change in the function of the kappa opioid system.
The results of Experiment 4 with DAMGO were surprising given previous work showing conditioned place preference to central administration of this selective mu agonist (Bals-Kubik et al., 1993; Madhavan et al., 2010) . However, differences in the route of administration, timing, and age of conditioning likely contribute to the differences between the above listed studies and ours. Alternatively, DAMGO may have affected the perception of the CS during the initial conditioning phase.
The kappa opioid system is of special interest with regard to prenatal ethanol exposure partly because of an established functional switch during normal ontogeny. In early infancy, activation of the kappa system is appetitive (Varlinskaya et al., 1996; Petrov et al., 2006) , whereas later in development kappa agonists induce aversion (Mucha and Herz, 1985; Shippenberg and Herz, 1986; Bals-Kubik et al., 1989) . Given the kappa system's established involvement in ethanol's aversive and dysphoric effects during late infancy and adulthood in non-dependent rats (Matsuzawa et al., 1999; Mitchell et al., 2005; Logrip et al., 2009) One possible explanation for the alteration in motivational sensitivity to kappa activation is that prenatal ethanol changes the expression of kappa opioid receptors in brain regions intimately related to ethanol responding. We found that kappa opioid receptor expression was decreased in the nucleus accumbens, amygdala, and hippocampus, but not the prefrontal cortex. Changes to opioid receptor expression following exposure to ethanol are not surprising in view of evidence that opioid peptides and receptors are altered following chronic alcohol exposure (Gianoulakis, 1996; Turchan et al., 1999; Chen and Lawrence, 2000; Lindholm et al., 2001) . In fact, ethanol exposure has been shown to influence the kappa opioid system specifically. For example, Rosin et al., (1999) reported that chronic ethanol exposure up-regulates kappa mRNA levels. Such effects are also suggested by behavioral tests showing that a kappa opioid antagonist blocks increased ethanol intake only in alcohol-dependent animals (Walker and Koob, 2008) . Taken together, these findings suggest an up-regulation of kappa opioid receptor expression due to prolonged ethanol exposure.
In the present work, decreased kappa expression following low levels of ethanol exposure seems to contribute to increased ethanol intake. While the underlying mechanisms for these effects are not clear at present, the previously identified developmental switch in kappa opioid receptor function during early development may be involved. These effects may also depend upon dose and duration of ethanol exposure. Potentially, specific cellular mechanisms such as associations with G proteins may underlie developmental and prenatal ethanol exposure effects. Furthermore, the persistence of reductions in kappa opioid function and expression needs to be investigated.
It is likely that trafficking of synaptosomal kappa opioid receptors also plays a major role in these effects of ethanol on the kappa opioid system, as has been shown for other receptors following ethanol exposure (reviewed in: Kumar et al., 2009 ). In particular, unpublished observations from our group indicate that total kappa opioid receptor expression in the nucleus accumbens following the same prenatal ethanol dose used here, albeit on prenatal day 12, displayed differences from controls. Although total expression needs to be further validated at the prenatal exposure age used here, together with the present results, this suggests that prenatal ethanol exposure might arrest synaptosomal trafficking mechanisms. Also, it is possible that the effects seen in this set of experiments persists into adolescence or even adulthood. Nonetheless, this is the first time that prenatal exposure at such low, albeit physiologically relevant, ethanol levels have been shown to exert such profound effects on kappa opioid function and expression.
While the current work focuses on the contributions of kappa opioid receptors, other opioid systems should also be assessed and contributions of non-opioid systems such as GABA and glutamate should be explored in the present context. While the limbic system has been a major focus, we cannot rule out changes in ethanol taste preference, as previous results indicate increased ethanol palatability following prenatal ethanol exposure (Arias and Chotro, 2005; Youngentob and Glendinning, 2009; Glendinning et al., 2012) .
Our previous work indicates that the doses used in the present studies do not produce changes in placenta weight, umbilical cord length, offspring's body weights, weights and/or size of the olfactory bulbs, cerebral hemispheres, and cerebellum or the granular layer of the olfactory bulb (Dominguez et al., 1998; Pueta et al., 2011) .
However, we cannot rule out that these low levels of prenatal ethanol exposure may produce other molecular teratological effects. Alternatively, these animals could have experienced difficulty learning. However, such a possibility is unlikely, given previous evidence that the present prenatal ethanol treatment does not preclude learning (Nizhnikov et al., 2006a; Pautassi et al., 2012b) . Additionally, the animals in the present study readily displayed learned preference for a texture paired with a kappa agonist and were therefore capable of conditioning.
In conclusion, the results presented here add to a growing literature indicating increased ethanol intake following prenatal ethanol exposure (see: Spear and Molina, 2005) and highlight limbic kappa opioid receptor involvement in the effects of prenatal ethanol exposure on ethanol intake later in life.
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Alati antagonist nor-BNI was given 24 hours prior to testing). The results indicate a significant increase in ethanol intake in prenatally untreated subjects for subjects receiving the high dose of nor-BNI on day 1 and both doses on days 4 and 5 (F(2,100) = 5.03, p<0.02).
Analysis for prenatally water treated animals indicated that the 2.5 mg/kg nor-BNI dose slightly, but significantly, increased ethanol intake on day 1 of testing. However, a more robust significant increase in ethanol intake following 2.5 mg/kg nor-BNI administration was seen on day 5, F(8, 120) = 2.07, p < 0.05. For prenatally ethanol treated subjects no effect of nor-BNI was seen. Asterisk indicates a significant difference from water controls. 
